• Aucun résultat trouvé

[PDF] Top 20 Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

Has 10000 "Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT" found on our website. Below are the top 20 most common "Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT".

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

... of children in this situation ...1–3% of liver and kidney, 3–9% of heart and lung and up to 10% of intestinal or multiorgan transplants ...increase the risk of acute ... Voir le document complet

10

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

... Nonmyeloablative Transplantation. In: Soiffer RJ, editor. Hematopoietic Stem Cell ...Kinetics of engraftment in patients with hematologic malignancies given ... Voir le document complet

7

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT

... METHODS Study design and data collection This is a retrospective multicenter analysis based on the registry data of the ALWP of the ...EBMT. ... Voir le document complet

8

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

... behalf of the STWP and CTIWP of EBMT Renal cell carcinoma (RCC) is particularly sensitive to immune ...HLA-G, a non-classical HLA class I molecule with immunomodulatory ... Voir le document complet

6

ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.

ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT.

... | Study design and data collection This multicenter retrospective analysis was approved by the ALWP, in accordance with the EBMT guidelines for retrospective ... Voir le document complet

8

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

... Methods Study design and data collection This was a retrospective multicenter analysis using the dataset of the Acute Leukemia Working Party (ALWP) of the ... Voir le document complet

12

Allogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT

Allogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT

... R A C T In this retrospective analysis we evaluated the outcome of 313 patients aged ≥ 70 years in the registry of the European Group for Blood and Marrow ... Voir le document complet

9

Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.

Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.

... because of the high pro- liferative capacity of blast cells and the delayed anti-leukemic effect of ...is a tyrosine kinase inhibitor that has substantial activity in ... Voir le document complet

2

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.

... that the overall efficacy of unmanipulated proDLI in acute leukaemia is moderate at best, at least if given as reported here, and improved strategies are required for relapse ...during the ... Voir le document complet

6

Prediction of allogeneic hematopoietic stem cell transplantation (allo-HSCT) related mortality in acute leukemia: generation of a machine learning-based model using the data set of the acute leukemia working party (ALWP) of the EBMT

Prediction of allogeneic hematopoietic stem cell transplantation (allo-HSCT) related mortality in acute leukemia: generation of a machine learning-based model using the data set of the acute leukemia working party (ALWP) of the EBMT

... Prediction Of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Related Mortality in Acute Leukemia: Generation Of a Machine Learning-Based ... Voir le document complet

3

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy

Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy

... Reduction of transplant-related toxicity is important as well as a reduction of the high rate of primary graft failure ...limiting the number of ... Voir le document complet

12

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial

Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial

... Our study has two important limitations. First, the target Hb value of 13 g/dL is no longer recommended by current guidelines because of the concern that this high Hb level may be ... Voir le document complet

7

A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation.

A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation.

... Luxembourg A 19-year old woman was diagnosed with acute biphenotypic ...analysis of the bone marrow detected a reciprocal translocation t(1;9)(p34-35;q34) in 10 out of 22 ... Voir le document complet

135

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the plasma cell disorders subcommittee of the european group for blood and marrow transplant chron

Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the plasma cell disorders subcommittee of the european group for blood and marrow transplant chronic malignancies working party

... from the Japanese registry, 11 reporting on a total of 86 patients between 2001 and ...2011. In both of these aforementioned studies, myeloablative chemotherapy and RIC were included, ... Voir le document complet

4

Limited sampling strategies for estimation of cyclosporine exposure in pediatric hematopoietic stem cell transplant recipients : methodological improvement and introduction of sampling time deviation analysis

Limited sampling strategies for estimation of cyclosporine exposure in pediatric hematopoietic stem cell transplant recipients : methodological improvement and introduction of sampling time deviation analysis

... double-blind, multicenter concentration-controlled trial for determining a therapeutic range of mycophenolate mofetil by Van Gelder et ...[9]. In the context of TDM, the ... Voir le document complet

223

A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.

A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.

... disease the working party decided that the 2013 revisions defin- ing the clinical course of multiple sclerosis should be used [ 27 ...]. In these criteria, progressive disease [whether ... Voir le document complet

8

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT

... Department of Hematology, Córdoba, Spain; Hospital Clínico Universitario, Servicio de Hematología, Valencia, Spain; Ospedale di Niguarda Ca ’ Granda, Hematology De- partment, Milano, Italy; University Hospital ... Voir le document complet

12

Allogenic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study for the French society for stem cell trans

Allogenic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study for the French society for stem cell transplantation (SFGM-TC)

... incidence of NRM and aGvHD in this elderly group likely reflects appropriate patient ...Given the retrospective nature of our analysis, and the heterogeneous patient population ... Voir le document complet

4

The use of mesenchymal stromal cells in solid organ transplantation

The use of mesenchymal stromal cells in solid organ transplantation

... properties of MSCs have been widely studied and include inhibition of T cell proliferation and func­ tion, inhibition of dendritic cell (DC) maturation, and induction of ... Voir le document complet

11

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

... included in the BeEAM and the BEAM groups, ...higher in the BeEAM than in the BEAM group (84% [73-96] ...However, the overall survival was not statistically ... Voir le document complet

49

Show all 10000 documents...